首页>
外国专利>
TANDEM REPEAT CANCER-TARGETING PEPTIDES FOR MOLECULAR CONJUGATION OR ENGINEERING AND USES THEREOF IN CANCER THERANOSTICS
TANDEM REPEAT CANCER-TARGETING PEPTIDES FOR MOLECULAR CONJUGATION OR ENGINEERING AND USES THEREOF IN CANCER THERANOSTICS
展开▼
机译:串联重复癌症靶向肽,用于分子缀合或工程及其在癌症治疗中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
An isolated cancer-targeting peptide that includes at least two copies of the amino acid sequence PFLP (SEQ ID NO: 1) or PELF (SEQ ID NO: 2). Also disclosed is a pharmaceutical composition for treating cancer. The composition contains the isolated cancer-targeting peptide and an anti-cancer agent. Further disclosed is a bispecific anti-cancer antibody that includes the isolated cancer targeting peptide and an antigen-binding peptide that stimulates T cell activity. Methods are provided for treating cancer by administering the pharmaceutical composition or the bispecific anti-cancer antibody. Further provided is a method for diagnosing cancer by administering a radionuclide-labeled cancer-targeting peptide to an individual and imaging a location of the radionuclide.
展开▼
机译:包含至少两份的氨基酸序列PFLP(SEQ ID NO:1)或PET(SEQ ID NO:2)的分离的癌症靶向肽。 还公开了用于治疗癌症的药物组合物。 该组合物含有分离的癌症靶向肽和抗癌剂。 进一步公开的是一种双特异性抗癌抗体,其包括刺激刺激T细胞活性的分离的癌症靶向肽和抗原结合肽。 提供了通过施用药物组合物或双特异性抗癌抗体治疗癌症的方法。 进一步提供的是通过向个体施用放射性核素标记的癌靶肽并成像放射性核素的位置来诊断癌症的方法。
展开▼